Wildy logo
(020) 7242 5778

Wildy’s Book News

Book News cover photo

Vol 22 No 5 May/June 2017

Book of the Month

Cover of Arlidge, Eady & Smith on Contempt

Arlidge, Eady & Smith on Contempt

Edited by: Patricia Londono, David Eady, A.T.H. Smith, Rt. Hon Lord Eassie
Price: £319.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...

Secondhand & Out of Print

Browse Secondhand Online


Contemporary Issues in Pharmaceutical Patent Law

Edited by: Bryan Mercurio, Daria Kim

ISBN13: 9781138934481
Published: February 2017
Publisher: Routledge
Country of Publication: UK
Format: Hardback
Price: £90.00

Low stock.

Also available as
+ £6.66 VAT

Developed and developing country governments around the world often struggle to provide prompt and affordable access to medicines for the populace and so maintain proper levels of health care at affordable prices.

This collection explores the complexities associated with the intersection of pharmaceutical law and policy and public health. Focusing on patent and relevant regulatory laws, the collection provides a comprehensive overview of the most important and pressing issues governments are currently facing in regards to ensuring access to medicines at an affordable cost. Each chapter focuses on a separate issue and offers clear, balanced and detailed analysis of the international framework, trends and available policy options.

Throughout, the volume emphasises the need for governments to think and act in a systemic manner and break away from the ‘silo’ method of dividing responsibilities between various government departments.

The book sets out ways in which law and policy in the area of pharmaceutical patents, health and policy can be integrated in order to ensure coherence and regulatory predictability.

Intellectual Property Law, Medical Law
1. Introduction – The Integration of Pharmaceutical Law and Policy: Objectives, Agenda and Mandate, Bryan Mercurio

Part 1: Patent Protection for Pharmaceutical Inventions
2. Patentability of Pharmaceuticals, Roberto Romandini and Henning Grosse Ruse-Khan
3. Extension of Patent Protection Term, Pei-Kan Yang
4. Biologics, Biosimilars and Patents, Yaniv Heled

Part 2: Balancing Patent Protection with Available Flexibilities
5. Experimental Use, Xavier Seuba
6. Compulsory Licensing: Threats, Use and Recent Trends, Chang-fa Lo Part 3: Patent Protection by Another Name
7. Data Exclusivity, Owais Hassan Shaikh
8. Patent Linkage, Bryan Mercurio
9. The Price of Exclusivity: the economics of patent extensions and data protection, Aidan Hollis
10. Regulatory Integrity in Pharmaceutical Innovation Framework, Daria Kim